Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway

Chordomas are radio- and chemo-resistant tumours and metastasise in as many as 40% of patients. The aim of this study was to identify potential molecular targets for the treatment of chordoma. In view of the reported association of chordoma and tuberous sclerosis complex syndrome, and the available...

Descripción completa

Detalles Bibliográficos
Autores principales: Presneau, N, Shalaby, A, Idowu, B, Gikas, P, Cannon, S R, Gout, I, Diss, T, Tirabosco, R, Flanagan, A M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694420/
https://www.ncbi.nlm.nih.gov/pubmed/19401700
http://dx.doi.org/10.1038/sj.bjc.6605019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694420/
https://www.ncbi.nlm.nih.gov/pubmed/19401700
http://dx.doi.org/10.1038/sj.bjc.6605019

Ejemplares similares